|
|
Line 12: |
Line 12: |
|
| |
|
| == Structural highlights == | | == Structural highlights == |
| | |
| | ==3D structures of importin== |
| | [[Importin 3D structures]] |
| | |
| </StructureSection> | | </StructureSection> |
|
| |
|
Line 55: |
Line 59: |
| *''IPO-α 1 complex with NLS peptide'' | | *''IPO-α 1 complex with NLS peptide'' |
|
| |
|
| | **[[4b18]] – hIPO NLS-binding domain + telomerase reverse transcriptase<br /> |
| | **[[4wv6]] – hIPO NLS-binding domain + TFIID<br /> |
| | **[[6bw0]] – hIPO NLS-binding domain + Nipa virus peptide<br /> |
| | **[[6bw1]] – hIPO NLS-binding domain + Hendra virus peptide<br /> |
| | **[[5w4e]], [[5w4f]], [[5w4g]] – hIPO NLS-binding domain + polymerase peptide<br /> |
| | **[[5h43]] – hIPO NLS-binding domain + histone acetyltransferase KAT8<br /> |
| **[[4mz5]], [[4mz6]] – mIPO NLS-binding domain + dUTPase<br /> | | **[[4mz5]], [[4mz6]] – mIPO NLS-binding domain + dUTPase<br /> |
| **[[4oih]] – mIPO NLS-binding domain + guanine nucleotide exchange factor SRM1<br /> | | **[[4oih]] – mIPO NLS-binding domain + guanine nucleotide exchange factor SRM1<br /> |
Line 70: |
Line 80: |
| **[[5klr]], [[5klt]] – mIPO NLS-binding domain + NLS <br /> | | **[[5klr]], [[5klt]] – mIPO NLS-binding domain + NLS <br /> |
| **[[5k9s]] – mIPO NLS-binding domain + HNF-b <br /> | | **[[5k9s]] – mIPO NLS-binding domain + HNF-b <br /> |
| **[[4b18]] – hIPO NLS-binding domain + telomerase reverse transcriptase<br /> | | **[[6iu7]], [[6iua]] – mIPO NLS-binding domain + TP53-binding protein <br /> |
| **[[4wv6]] – hIPO NLS-binding domain + TFIID<br />
| |
| **[[6bw0]] – hIPO NLS-binding domain + Nipa virus peptide<br />
| |
| **[[6bw1]] – hIPO NLS-binding domain + Hendra virus peptide<br />
| |
| **[[5w41]] – mIPO NLS-binding domain + Zika virus peptide <br /> | | **[[5w41]] – mIPO NLS-binding domain + Zika virus peptide <br /> |
| **[[5v5o]], [[5v5p]] – mIPO NLS-binding domain + influenza virus peptide <br /> | | **[[5v5o]], [[5v5p]] – mIPO NLS-binding domain + influenza virus peptide <br /> |
Line 79: |
Line 86: |
| **[[5u5p]], [[5u5r]] – mIPO NLS-binding domain + MLH1 peptide <br /> | | **[[5u5p]], [[5u5r]] – mIPO NLS-binding domain + MLH1 peptide <br /> |
| **[[5gxw]] – mIPO NLS-binding domain + NUMA peptide <br /> | | **[[5gxw]] – mIPO NLS-binding domain + NUMA peptide <br /> |
| **[[5w4e]], [[5w4f]], [[5w4g]] – hIPO NLS-binding domain + polymerase peptide<br />
| |
| **[[5h43]] – hIPO NLS-binding domain + histone acetyltransferase KAT8<br />
| |
| **[[4b8o]] – rIPO NLS-binding domain + SV40<br /> | | **[[4b8o]] – rIPO NLS-binding domain + SV40<br /> |
| **[[4b8p]] – rIPO NLS-binding domain + A89<br /> | | **[[4b8p]] – rIPO NLS-binding domain + A89<br /> |
Line 155: |
Line 160: |
| *''IPO-β 1 complex with protein'' | | *''IPO-β 1 complex with protein'' |
|
| |
|
| **[[1qgx]], [[1qgr]] – hIPO + IPO-α 2 IBB domain<br /> | | **[[1qgx]], [[1qgk]] – hIPO + IPO-α 2 IBB domain<br /> |
| **[[1ibr]] – hIPO + GTPase Ran<br /> | | **[[1ibr]] – hIPO + GTPase Ran<br /> |
| **[[2bku]], [[3ea5]] – yIPO + GTPase Ran<br /> | | **[[2bku]], [[3ea5]] – yIPO + GTPase Ran<br /> |
Line 196: |
Line 201: |
| **[[5xah]] – hIPO residues 668-1081 <br /> | | **[[5xah]] – hIPO residues 668-1081 <br /> |
| **[[5xbk]] – hIPO residues 668-1081 + histone H3 peptide <br /> | | **[[5xbk]] – hIPO residues 668-1081 + histone H3 peptide <br /> |
| | |
| | *IPO-7 |
| | |
| | **[[6n88]] – IPO + hIPO-90 + histone H1.0 – frog – Cryo EM <br /> |
| | |
| | *IPO-9 |
| | |
| | **[[6n1z]] – hIPO + histone H2A + histone H2B <br /> |
|
| |
|
| *IPO-12 (Transportin-3) | | *IPO-12 (Transportin-3) |
Line 208: |
Line 221: |
| **[[2xwu]] – hIPO + UBC9<br /> | | **[[2xwu]] – hIPO + UBC9<br /> |
| **[[3zjy]] – hIPO + GTPase Ran + EIF-1A<br /> | | **[[3zjy]] – hIPO + GTPase Ran + EIF-1A<br /> |
| | |
| | *IPO-90 |
| | |
| | **[[6n89]] – hIPO-90 + histone H1.0 – Cryo EM <br /> |
| }} | | }} |
|
| |
|
FunctionImportins (IPO) mediate the import of cellular proteins into the nucleus by binding to the Nuclear Localization Signal (NLS). IPO has 2 subunits: α and β. IPO-α is an adaptor protein which binds the NLS[1]. IPOs can contain one or two NLS motifs. IPO-α contains several armadillo repeats with two NLS-binding sites and an IPO-β binding (IBB) site. IPO-β contains 19 HEAT (solenoid domain) repeats. Many nuclear proteins contain Phe-Gly sequences which can bind to HEAT repeats and thus be transported. See also Protein Transport Membrane Protein.
DiseaseIPO-α isoform expression is altered in many kinds of cancer.
RelevanceSpecific IPO-α isoforms are critical in nerve regenerative response after injury. Loss of IPO-α expression in aging myocardial cells could make recovery after heart disease in elderly patients more difficult[2].
Structural highlights3D structures of importinImportin 3D structures
| |
3D structures of importin3D structures of importin
Updated on 27-August-2019
{"openlevels":0}
- IPO-α
- 1ial – mIPO NLS-binding domain – mouse
- 1bk5 – yIPO NLS-binding domain - yeast
- 4tnm – IPO armadillo repeat domain – Arabidopsis thaliana
- IPO-α complex with NLS peptide
- 1ejl – mIPO NLS-binding domain + SV40 large T antigen
- 1ejy – mIPO NLS-binding domain + nucleoplasmin
- 2ynr – mIPO NLS-binding domain + B54NLS
- 2yns – rIPO NLS-binding domain + B54NLS - rice
- 1bk6 – yIPO NLS-binding domain + SV40 large T antigen
- 1ee4 – yIPO NLS-binding domain (mutant) + c-Myc
- 1ee5 – yIPO NLS-binding domain (mutant) + nucleoplasmin
- 1un0, 2c1t – yIPO NLS-binding domain (mutant) + Nup2
- 5h2x, 5h2w – yIPO NLS-binding domain + ubiquitin-like specific protease
- 4xzr – yIPO NLS-binding domain + HEH1
- 4pvz – yIPO NLS-binding domain + HEH2
- 4rxh – NcIPO NLS-binding domain + SV40 large T antigen – Neurospora crassa
- 5vqi – NcIPO NLS-binding domain + NIT2
- IPO-α complex with protein
- 1wa5 – yIPO NLS-binding domain + GTPase Ran + IPO-α re-exporter
- 5t94 – yIPO NLS-binding domain + guanine nucleotide exchange factor
- 5mfm – yIPO NLS-binding domain + YIIIM6AII
- IPO-α 1
- 3wpt – hIPO NLS-binding domain - human
- 4b8j – rIPO
- 6bvt – mIPO NLS-binding domain
- IPO-α 1 complex with NLS peptide
- 4b18 – hIPO NLS-binding domain + telomerase reverse transcriptase
- 4wv6 – hIPO NLS-binding domain + TFIID
- 6bw0 – hIPO NLS-binding domain + Nipa virus peptide
- 6bw1 – hIPO NLS-binding domain + Hendra virus peptide
- 5w4e, 5w4f, 5w4g – hIPO NLS-binding domain + polymerase peptide
- 5h43 – hIPO NLS-binding domain + histone acetyltransferase KAT8
- 4mz5, 4mz6 – mIPO NLS-binding domain + dUTPase
- 4oih – mIPO NLS-binding domain + guanine nucleotide exchange factor SRM1
- 5svz – mIPO NLS-binding domain + TAT NLS motif
- 5wum, 5wun, 5x8n – mIPO NLS-binding domain + Epstein Barr antigen
- 5huw – mIPO NLS-binding domain + HSVI large terminase
- 5huy – mIPO NLS-binding domain + HSMV small terminase
- 5hhg, 5fc8 – mIPO NLS-binding domain + dengue 2 NS5
- 5ekg, 5ekf, 5e6q – mIPO NLS-binding domain + XPG2
- 5d5k – mIPO NLS-binding domain + PARP 2
- 5ctt – mIPO NLS-binding domain + SART3/TIP110
- 5b56 – mIPO NLS-binding domain + HIV-1 VPR
- 4zdu – mIPO NLS-binding domain + influenza nucleoprotein
- 4yi0 – mIPO NLS-binding domain + Nup121
- 5klr, 5klt – mIPO NLS-binding domain + NLS
- 5k9s – mIPO NLS-binding domain + HNF-b
- 6iu7, 6iua – mIPO NLS-binding domain + TP53-binding protein
- 5w41 – mIPO NLS-binding domain + Zika virus peptide
- 5v5o, 5v5p – mIPO NLS-binding domain + influenza virus peptide
- 5umz – mIPO NLS-binding domain + TNRC6A peptide
- 5u5p, 5u5r – mIPO NLS-binding domain + MLH1 peptide
- 5gxw – mIPO NLS-binding domain + NUMA peptide
- 4b8o – rIPO NLS-binding domain + SV40
- 4b8p – rIPO NLS-binding domain + A89
- 4bpl – rIPO NLS-binding domain + nucleoplasmin
- 4bqk – rIPO NLS-binding domain + VirD2
- IPO-α 1 complex with protein
- 2jdq – hIPO NLS-binding domain + polymerase basic protein 2 C terminal
- 3tj3 – hIPO NLS-binding domain + Nup50 N terminal
- 2jdq – hIPO NLS-binding domain + telomerase reverse transcriptase peptide
- 4uaf – mIPO NLS-binding domain + influenza RNA polymerase
- IPO-α 2
- 3tpo – mIPO
- 1iq1 – mIPO NLS-binding + autoinhibitory peptide domains
- 4e4v – hIPO NLS-binding domain (mutant)
- IPO-α 2 complex with NLS peptide
- 1pjm – mIPO NLS-binding domain + retinoblastoma-associated protein
- 1pjn – mIPO NLS-binding domain + histone-binding protein N1/N2
- 1q1s, 1q1t – mIPO NLS-binding domain + SV40 large T antigen
- 1y2a, 3q5u – mIPO NLS-binding domain + phospholipid scramblase
- 2c1m – mIPO NLS-binding domain + Nup50
- 3btr – mIPO NLS-binding domain + androgen receptor
- 3knd – mIPO NLS-binding domain + targeting protein for KXLP2
- 3l3q – mIPO NLS-binding domain + library peptide
- 3oqs – mIPO NLS-binding domain + CLIC4
- 3rz9 – mIPO NLS-binding domain + KU80
- 3rzx – mIPO NLS-binding domain + KU70
- 3tpm – mIPO NLS-binding domain + MAL
- 3ve6 – mIPO NLS-binding domain + Venezuelan equine encephalitis virus
- 3uvu – mIPO NLS-binding domain + flap endonuclease
- 3ukw, 3ukx – mIPO NLS-binding domain + BIMAX
- 3uky, 3ukz, 3ul0 – mIPO NLS-binding domain + nuclear CAP-binding protein
- 3ul1 – mIPO NLS-binding domain + nucleoplasmin
- 4htv – mIPO NLS-binding domain + capsid protein
- 4ba3 – mIPO NLS-binding domain + A89NLS
- 3zio, 3zip, 3ziq, 3zir – mIPO NLS-binding domain + minor site-specific NLS
- 3zin – mIPO NLS-binding domain + nucleolar RNA helicase
- IPO-α 2 complex with protein
- 3fex, 3fey – mIPO NLS-binding domain + nuclear CAP-binding protein
- IPO-α 3
- 6bvz – hIPO NLS-binding domain
- 4uae – hIPO NLS-binding domain + influenza RNA polymerase
- 6bw9, 6bwa, 6bwb – hIPO NLS-binding domain + Hendra virus peptide
- 6bvv – hIPO NLS-binding domain + Nipa virus peptide
- 5xzx – hIPO NLS-binding domain + RAN-binding protein peptide
- 5tbk – hIPO NLS-binding domain + regulator of chromosome condensation
- IPO-α 6
- 4u2x – hIPO C terminal + ebola VP24
- IPO-α 7
- 4uad – hIPO NLS-binding domain + influenza RNA polymerase
- IPO-β
- 4xrk – IPO – Chaetomium thermophilum
- IPO-β 1 (karyopherin β 1)
- IPO-β 1 complex with protein
- 1qgx, 1qgk – hIPO + IPO-α 2 IBB domain
- 1ibr – hIPO + GTPase Ran
- 2bku, 3ea5 – yIPO + GTPase Ran
- 1f59, 1o6p, 1o6o – hIPO + FXFG nucleoporin repeats
- 1m5n – hIPO HEAT repeats 1-11 + parathyroid hormone-related protein NLS peptide
- 2p8q, 2q5d, 2qna, 3lww – hIPO + RNA U transporter N terminal
- 1qgr, 3w5k – hIPO + zinc finger protein SNAI1
- 5owu – yIPO + Nup1
- 1ukl – mIPO + SREBP-2
- IPO-β 2 (Transportin 1)
- IPO-β 2 complex with protein
- IPO-β 3 (Karyopherin β 3)
- 3w3t – yIPO
- 3w3u, 3w3v – yIPO (mutant)
- 3w3w – yIPO + STE12P
- 3w3x – yIPO + PHO4
- 3w3y – yIPO + Nup53P
- 3w3z – yIPO + RANGTP
- 5h2v – yIPO + ubiquitin-like specific protease
- 4zj7 – yIPO + CDC14
- IPO-4B
- 5xah – hIPO residues 668-1081
- 5xbk – hIPO residues 668-1081 + histone H3 peptide
- IPO-7
- 6n88 – IPO + hIPO-90 + histone H1.0 – frog – Cryo EM
- IPO-9
- 6n1z – hIPO + histone H2A + histone H2B
- IPO-12 (Transportin-3)
- 4c0p – hIPO
- 4c0o – hIPO + serine/arginine-rich splicing factor
- 4c0q, 4ol0 – hIPO + GTPase Ran
- IPO-13 (karyopherin 13)
- 2x19 – hIPO + GTPase Ran
- 2xwu – hIPO + UBC9
- 3zjy – hIPO + GTPase Ran + EIF-1A
- IPO-90
- 6n89 – hIPO-90 + histone H1.0 – Cryo EM
ReferencesReferences